CLINICAL CASE DISCUSSION ON community acquired pneumonia Dr Nikita Ingale
A Clinical case discussion on community acquired pneumonia
A glance at how actually a prescription must be! finding rational and irrational prescriptions!
Presentation on all the evaluation methods in animals for anti-aarhythmics. It includes in vivo and in vitro methods. I have explained Langendorffs technique in detail.
Presentation on recent advances in Parkinsons disease. Tried to cover up new drugs as well as new devices like Duodopa set up. . i have tried to put a light on the established treatment of Parkinson's disease along with its mechanism of actions in circuit loops which will help to understand the topic in depth!
Presentation on recent advances in congestive cardiac failure. tried to cover up BNP analogues, Angiotensin receptor neprilysin inhibitor(ARNI) and novel drugs like levosimendan. i have tried to put a light on the established treatment of cardiac failure along with its mechanism of actions which will help to understand the topic in depth!
Presentation on all the evaluation methods in animals for anti diabetics. It includes methods for insulin dependant and insulin independent diabetes mellitus!
short presentation an all the oral as well as injectable hormonal contraceptives, inclusive of their mechanism of actions , adverse effects and advantages.
Presentation on the established and new drug therapies in drug resistant tuberculosis. Also, includes few basic slides on first line therapy for drug sensitive Tuberculosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
1. CLINICAL CASE
DISCUSSION
- Dr Nikita Ingale
Jr1, Pharmacology
GMCH Nagpur
Guide-
- Dr Vijay Motghare
Professor and Head
Pharmacology
GMCH Nagpur
2. Patients profile
Name-xyz
Age- 22 years
Sex- female
Reg. no.------
DOA- 21-01-2018 at 2.45 pm, Admitted in ward
Diagnosis-Primigravida with 36 weeks with antepartum eclampsia
29-07-2019 2
3. - Pt admitted to wd 22 through casualty reference from DHW hospital
Amaravati as primi with 32 weeks with eclampsia
- Pt complained of mild headache since last 15 days
- She developed pedal odema over the days with slight abdominal pain
- She did not consult any local doctor for any complaint
Admission Notes
29-07-2019CCD - Eclampsia 3
4. - Patient suddenly suffered from 1st episode of convulsions at 4 am in the
home followed by 2nd episode at 5 am
- she was taken to the Duffrin hospital, Amravati at 5 am
- Patient suffered from 3rd and 4th episodes of convulsion in the hospital
- Patient received 1 loading dose of MgSO4 in the hospital
- Patient had done ANC registration at PHC Pimpalgaon
- Not done any ANC USG
29-07-2019
CCD - Eclampsia
4
8. 29-07-2019CCD - Eclampsia 8
Treatment on 21-01-18 at 3.45 pm
- Folleys catheter introduced under aseptic condition
- Inj MgSO4 6 gm IV 1ST IV Maintainance dose
BP = 150/100 mm Hg
Resp rate = 16/ min
Urine output = 200 cc
Deep tendon reflexes = brisk
9. 29-07-2019CCD - Eclampsia 9
Treatment on 21-01-18 at 11 pm
- Inj Taxim 1 gm IV
- Inj Mannitol 100 mg
- Inj Metro 100 mg IV
- Conscious
afebrile
pallor +
BP = 150/100 mm Hg
Pulse = 80/ min
Resp rate = 18/ min
10. 29-07-2019CCD - Eclampsia 10
Treatment on 22-01-18 at 00:35 AM
- Inj Lasix 20 mg
- Dextrose 5% 500 ml
- Inj Pitocin 10 units
- Conscious
afebrile
pallor +
BP = 140/100 mm Hg
Pulse = 78/ min
Resp rate = 18/ min
11. 29-07-2019CCD - Eclampsia 11
Treatment on 22-01-18 at 06:00 AM
- Inj Taxim 1 gm IV
- Inj Metro 0.5 gm IV
- Tablet Labet 100 mg
- Tablet Rantac 50 mg
- Tablet Voveron
- Conscious
afebrile
pallor +
BP = 150/100 mm Hg
Pulse = 80/ min
Resp rate = 16/ min
12. 29-07-2019
CCD - Eclampsia
12
Fundus examination on 22-01-18 at 5 pm
- Red glow seen
- Disc = clearly seen and normal
- Macula =normal
- No macular odema
- Periphery within normal limits
- Bilaterally fundus was normal
13. 29-07-2019
CCD - Eclampsia
13
Lect notes on 22-01-18 at 5.30 pm
- GC – Conscious
- Afebrile
- Pallor +
- Pulse = 90/ min
- BP= 170/100 mm Hg
- Per abdominal
- soft
- FHS +
ADVISED-
-Tablet Labet 200 mg
stat
-NST to be done stat
-BP monitoring 1
hrly
14. 29-07-2019CCD - Eclampsia 14
Reg notes on 22-01-18 at 7.30 pm
- GC – Conscious
- Afebrile
- Pallor +
- Pulse = 84/ min
- BP= 140/90 mm Hg
- ARM Done liqor clear
- Tablet Misoprostol 25 mg
15. 29-07-2019 15
Reg notes on 23-01-18 at 00:35 AM
- Baby delivered vaginally ,Male child at 12:20 am
- Baby weight 1.6 kg
- Inj Pitocin 10 units
- Inj Taxim 1 gm IV
- Inj Metro 0.5 gm IV
- Inj Lasix 20 mg IV stat
- Tablet Labet 100 mg
- Tablet voveron
- Continue MgSO4
- Conscious
afebrile
pallor +
BP = 130/90 mm Hg
Pulse = 74/ min
Resp rate = 16/ min
16. 29-07-2019CCD - Eclampsia 16
Reg notes on 23-01-18 at 7:00 AM
- Inj MgSO4 6 gm in infusion pump started 2nd IV Maintainance dose
BP = 130/90 mm Hg
Resp rate = 18/ min
Urine output = 600 cc
Deep tendon reflexes = normal
17. 29-07-2019
CCD - Eclampsia
17
Reg notes on 23-01-18 at 10:00 AM
BP = 120/70 mm Hg
Pulse = 72/ min
Resp rate = 18/ min
- GC – Conscious
- Afebrile
- Pallor +
- Inj Taxim 1 gm IV
- Inj Metro 0.5 gm IV
- Tablet Labet 100 mg
- Tablet Rantac 50 mg
- Tablet Voveron
- Continue MgSO4
18. 29-07-2019
CCD - Eclampsia
18
Reg notes on 23-01-18 at 4:00 PM
BP = 130/70 mm Hg
Pulse = 74/ min
Resp rate = 18/ min
- GC – Conscious
- Afebrile
- Pallor +
- Inj Taxim 1 gm IV
- Inj Metro 0.5 gm IV
- Tablet Labet 100 mg
- Tablet Rantac 50 mg
- Tablet Voveron
- Continue MgSO4
19. 29-07-2019CCD - Eclampsia 19
Reg notes on 23-01-18 at 5:00 PM
Inj MgSO4 6 gm in infusion pump continued after assessing all parameters
BP = 130/70 mm Hg
Resp rate = 18/ min
Urine output = 800 cc
Deep tendon reflexes = normal
20. 29-07-2019
CCD - Eclampsia
20
Current status of patient-
patient’s BP got stabilized
Same medications were continued for 3 more days
She got discharged from the hospital on 27-01-18
Baby is admitted in neonatology department undergoing care for its prematurity
22. 29-07-2019
CCD - Eclampsia
22
Hypertension in pregnancy
Hypertension BP >140/90 measured 2 times in 6 hr interval
Proteinuria urine excretion of > 0.3 gm/ 24 hrs
Gestational hypertension BP >140/90 for first time in preg after 20 wks wthout proteinuria
Pre eclampsia gestational hypertension with proteinuria
Eclampsia preeclampsia complicated with convulsions
Chronic hypertension hypertension before pregnancy or first time in pregnancy before 20 wks
Superimposed preeclampsia new onset of proteinuria with chronic hypertension
23. 29-07-2019
CCD - Eclampsia
23
Etiopathogenesis of eclampsia-
- Basic pathology is endothelial dysfunction and intense vasospasm
Normally in pregnancy
In 1st trimester, trophoblasts invades decidua
In 2nd trimester, trophoblasts invades myometrium
Spiral arterioles become tortuous, distended
Spiral arterioles become low resistance
Low pressure and high flow system
Preeclampsia
/ eclampsia
24. 29-07-2019CCD - Eclampsia 24
Causes of convulsions-
Cerebral odema may contribute to irritation
Anoxia spasm of the cerebral vessels
increased cerebral vascular resistance
fall in cerebral oxygen consumption
anoxia
26. 29-07-2019CCD - Eclampsia 26
Management of Eclampsia-
General Specific
- Supportive care
- Detailed history
- Examination
- Monitoring
- Fluid balance
27. 29-07-2019
CCD - Eclampsia
27
Specific Management of Eclampsia-
MgSO4 is the drug of choice
Intramuscular
/ pritchard
Intravenous/
zuspan
4 gm IV over 3 mins followed by
10 gm deep IM LOADING DOSE
5 gm IM 4 hrly in alternate buttock
MAINTENANCE DOSE
5 gm IV in 20 mins
LOADING DOSE
2 gm/hr IV infusion
MAINTENANCE DOSE
Therapeutic level of serum
magnesium should be 3-6
mEQ/L
28. 29-07-2019CCD - Eclampsia 28
Antihypertensives and diuretics-
Only if BP is more
than 160/110 mm Hg
Hydralazine
Labetalol
Calcium channel
blockers
Nitroglycerine
29. 29-07-2019CCD - Eclampsia 29
Antihypertensives and diuretics-
FRUSEMIDE 20-40
mg intravenously
- Presence of
pulmonary odema
30. 29-07-2019CCD - Eclampsia 30
Rationality -
Tablet labetelol adrenoceptor antagonist[ alpha + beta]
safe antihypertensive in pregnancy
appropriate dose used
Injection MgSO4 Drug of choice for eclampsia
decreases maternal mortality, prevents recurrence
31. 29-07-2019CCD - Eclampsia 31
Injection taxim
Injection metronidazole taxim is 3rd generation cephalosporin containing cefotaxime
metronidazole is nitroimidazole antimicrobial
prevents hospital acquired, superimposed infections
Injection pitocin content is oxytocin
used for induction of labor
Injection rantac H2 blocker
reduce GI upset if caused by use of antibiotics
Rationality -
32. 29-07-2019CCD - Eclampsia 32
Irrationality -
Injection mannitol osmotic diuretic
no indication in this case
Injection dexamethasone steroid
no indication during emergency termination of pregnancy
Injection lasix loop diuretic
diuretics contraindicated in preg
33. 29-07-2019 33
Irrationality -
Tablet voveron diclofenac [ NSAID ]
No indication
Brand names were used tab labet, inj taxim, tab voveron
Short forms were used
Doses were not mentioned
34. References
- Hiralal konar, D.C Dutta, Text book of obstetrics, 7th edition, 2011, kolkata,
chapter 17, hypertensive disorders in pregnancy;p219-40
- HL Sharma & KK Sharma. Drugs therapy of hypertension. sharma and
sharma’s principles of pharmacology. 3rd edition. hyderabad, Paras Medical
Publisher;2017.p262-82
- Leveno KJ, Alexander JM, Bloom SL, Casey BM, Dashe JS., Roberts SW, et
al., editors. Williams manual of pregnancy and hypertension. 23rd ed. New
York: McGrawHill Medical; 2013
-The use of magnesium sulphate for the treatment of severe pre-eclampsia
and eclampsia, Annals of African Medicine Vol. 8, No. 2; 2009:76-80
36. 29-07-2019CCD - Eclampsia 36
Clinical features of Eclampsia-
Premonitory stage unconscious, twitching muscles, eye balls roll, stage is for 30 sec
Tonic stage tonic spasm of body, eye balls fixed, tongue protrudes out, cyanosis, 30 sec
Clonic stage vol muscles go contraction and relaxation, biting of tongue, blood stained frothy
saliva, 2 mins
Coma stage pt goes in deep coma, last for brief period